Loading…
Effect of different doses of GLP-2 (Teduglutide) on acute esophageal lesion due to acid-pepsin perfusion in male rats
► Acid-pepsin perfusion by pump induced esophageal lesions in rat. ► Pre-administration of GLP-2 (Teduglutide) with acid-pepsin perfusion, significantly reduced esophageal complications and lesion size. ► The GLP-2 (Teduglutide) healing effect on esophageal lesion due to NO pathway. Gastro-esophagea...
Saved in:
Published in: | Peptides (New York, N.Y. : 1980) N.Y. : 1980), 2011-10, Vol.32 (10), p.2086-2090 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | ► Acid-pepsin perfusion by pump induced esophageal lesions in rat. ► Pre-administration of GLP-2 (Teduglutide) with acid-pepsin perfusion, significantly reduced esophageal complications and lesion size. ► The GLP-2 (Teduglutide) healing effect on esophageal lesion due to NO pathway.
Gastro-esophageal reflux currently is widespread disorders with dangerous complications. GLP-2 is a peptide that has trophic and anti-inflammatory effects on gastrointestinal mucosa. The aim of this study was to evaluate the protective role of GLP-2 in esophageal mucosa lesion due to perfusion acid-pepsin. Thirty-six male rats were used in this study and divided into six groups. They were control, acid-pepsin, GLP-2 20μg, GLP-2 30μg, GLP-2 40μg and GLP-2 50μg/kg groups. Esophageal blood flow, plasma NO metabolite, esophageal tissue NO metabolites and histological study of esophagus were performed as indicators of esophageal damage following acid-pepsin perfusion. Results showed that GLP-2 significantly increased plasma and tissue NO metabolites in comparison to acid-pepsin group. Also histological study showed significantly fewer lesions in the most effective dose GLP-2 30μg in comparison to acid-pepsin group, our results show that GLP-2 could be useful for the treatment of esophageal in animal model. |
---|---|
ISSN: | 0196-9781 1873-5169 |
DOI: | 10.1016/j.peptides.2011.09.004 |